Ignacio Dolado

1.3k total citations
20 papers, 1.0k citations indexed

About

Ignacio Dolado is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Ignacio Dolado has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 3 papers in Reproductive Medicine. Recurrent topics in Ignacio Dolado's work include Melanoma and MAPK Pathways (7 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Cancer-related Molecular Pathways (5 papers). Ignacio Dolado is often cited by papers focused on Melanoma and MAPK Pathways (7 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Cancer-related Molecular Pathways (5 papers). Ignacio Dolado collaborates with scholars based in Spain, Switzerland and United Kingdom. Ignacio Dolado's co-authors include Ángel R. Nebreda, Ana Cuadrado, Aneta Swat, Gabriella De Vita, Nuria Ajenjo, Ana Igea, Begoña Cánovas, Philip Cohen, Susana Llanos and José M. Rojas and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Nature Cell Biology.

In The Last Decade

Ignacio Dolado

20 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignacio Dolado Spain 11 695 333 170 107 102 20 1.0k
Ana Igea Spain 14 793 1.1× 260 0.8× 191 1.1× 111 1.0× 124 1.2× 25 1.1k
Sun Young Yoon South Korea 18 816 1.2× 319 1.0× 295 1.7× 74 0.7× 154 1.5× 56 1.3k
Lynn Ueno United States 9 630 0.9× 221 0.7× 148 0.9× 75 0.7× 126 1.2× 13 910
Ki Beom Bae South Korea 20 526 0.8× 309 0.9× 142 0.8× 74 0.7× 112 1.1× 69 1.2k
Javier Martínez‐Useros Spain 21 671 1.0× 383 1.2× 336 2.0× 175 1.6× 97 1.0× 55 1.2k
Lei Bi China 17 543 0.8× 218 0.7× 215 1.3× 89 0.8× 95 0.9× 46 977
Fei Chu United States 16 574 0.8× 381 1.1× 181 1.1× 41 0.4× 119 1.2× 34 1.1k
Joan Lewis-Wambi United States 20 631 0.9× 424 1.3× 323 1.9× 82 0.8× 141 1.4× 31 1.3k
Md Kamrul Hasan United States 19 611 0.9× 316 0.9× 163 1.0× 77 0.7× 140 1.4× 43 1.1k
Hyunho Yoon South Korea 16 569 0.8× 365 1.1× 277 1.6× 86 0.8× 123 1.2× 30 1.1k

Countries citing papers authored by Ignacio Dolado

Since Specialization
Citations

This map shows the geographic impact of Ignacio Dolado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Dolado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Dolado more than expected).

Fields of papers citing papers by Ignacio Dolado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Dolado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Dolado. The network helps show where Ignacio Dolado may publish in the future.

Co-authorship network of co-authors of Ignacio Dolado

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Dolado. A scholar is included among the top collaborators of Ignacio Dolado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Dolado. Ignacio Dolado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huepenbecker, Sarah P., Jason D. Wright, Mary K. Downer, et al.. (2022). Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer. Obstetrics and Gynecology. 140(5). 758–767. 3 indexed citations
2.
Meyer, Larissa A., Jonathan Wright, Mary K. Downer, et al.. (2020). Patterns and adoption of BRCA testing in ovarian cancer in the real world: Observations from Flatiron Health. Gynecologic Oncology. 159. 29–30. 1 indexed citations
3.
Korach, Jacob, Nicoletta Colombo, César Mendiola, et al.. (2019). Outcome according to residual disease (surgeon's report vs pre‐chemotherapy imaging) in patients with bevacizumab‐treated ovarian cancer: Analysis of the ROSiA study. Journal of Surgical Oncology. 120(4). 786–793. 3 indexed citations
5.
Fiedler, Ulrike, Christof Zitt, Martin Béhé, et al.. (2017). Abstract P4-21-18: Pre-clinical antitumor activity, tumor localization, and pharmacokinetics of MP0274, an apoptosis inducing, biparatopic HER2-targeting DARPin®. Cancer Research. 77(4_Supplement). P4–21. 5 indexed citations
6.
Binz, Hans, Talitha R. Bakker, Douglas J. Phillips, et al.. (2017). Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate. mAbs. 9(8). 1262–1269. 51 indexed citations
7.
Fiedler, Ulrike, Savira Ekawardhani, Talitha R. Bakker, et al.. (2017). MP0250, a VEGF and HGF neutralizing DARPin® molecule shows high anti-tumor efficacy in mouse xenograft and patient-derived tumor models. Oncotarget. 8(58). 98371–98383. 17 indexed citations
8.
Rodón, Jordi, Aurelius Omlin, Karin H. Herbschleb, et al.. (2015). Abstract B25: First-in-human Phase I study to evaluate MP0250, a DARPin blocking HGF and VEGF, in patients with advanced solid tumors. Molecular Cancer Therapeutics. 14(12_Supplement_2). B25–B25. 7 indexed citations
9.
Urosevic, Jelena, Xabier García‐Albéniz, Evarist Planet, et al.. (2014). Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. Nature Cell Biology. 16(7). 685–694. 114 indexed citations
10.
Fiedler, Ulrike, et al.. (2014). Potency of bortezomib in combination with MP0250, a bispecific VEGF- and HGF-targeting darpin, in a preclinical multiple myeloma model.. Journal of Clinical Oncology. 32(15_suppl). e19574–e19574. 3 indexed citations
11.
Igea, Ana, et al.. (2013). Inhibition of p38 MAPK sensitizes tumour cells to cisplatin‐induced apoptosis mediated by reactive oxygen species and JNK. EMBO Molecular Medicine. 5(11). 1759–1774. 119 indexed citations
12.
Dolado, Ignacio, et al.. (2013). Abstract P4-12-30: A bivalent Her2 targeting DARPin with high efficacy against Her2-low and Her2-positive tumors. Cancer Research. 73(24_Supplement). P4–12. 4 indexed citations
13.
Swat, Aneta, Ignacio Dolado, Ana Igea, et al.. (2011). Expression and functional validation of new p38α transcriptional targets in tumorigenesis. Biochemical Journal. 434(3). 549–558. 2 indexed citations
14.
Swat, Aneta, Ignacio Dolado, José M. Rojas, & Ángel R. Nebreda. (2009). Cell Density-Dependent Inhibition of Epidermal Growth Factor Receptor Signaling by p38α Mitogen-Activated Protein Kinase via Sprouty2 Downregulation. Molecular and Cellular Biology. 29(12). 3332–3343. 40 indexed citations
15.
Dolado, Ignacio, Aneta Swat, Nuria Ajenjo, et al.. (2007). p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis. Cancer Cell. 11(2). 191–205. 336 indexed citations
16.
Cuadrado, Ana, Vanesa Lafarga, Peter Cheung, et al.. (2007). A new p38 MAP kinase‐regulated transcriptional coactivator that stimulates p53‐dependent apoptosis. The EMBO Journal. 26(8). 2115–2126. 73 indexed citations
17.
Rousseau, Simon, Ignacio Dolado, Natalia Shpiro, et al.. (2006). CXCL12 and C5a trigger cell migration via a PAK1/2-p38α MAPK-MAPKAP-K2-HSP27 pathway. Cellular Signalling. 18(11). 1897–1905. 102 indexed citations
18.
Alfonso, Patricia, Ignacio Dolado, Aneta Swat, et al.. (2006). Proteomic analysis of p38α mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblasts. PROTEOMICS. 6(S1). S262–S271. 21 indexed citations
19.
Dolado, Ignacio, et al.. (2005). Kinetic Assay for High-Throughput Screening of In Vitro Transthyretin Amyloid Fibrillogenesis Inhibitors. Journal of Combinatorial Chemistry. 7(2). 246–252. 37 indexed citations
20.
Faust, Dagmar, Ignacio Dolado, Ana Cuadrado, et al.. (2005). p38α MAPK is required for contact inhibition. Oncogene. 24(53). 7941–7945. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026